|
A Controlled Study of Olanzapine in Children with Autism Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about A Controlled Study of Olanzapine in Children with Autism conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Controlled Study of Olanzapine in Children with Autism Clinical research trials and A Controlled Study of Olanzapine in Children with Autism healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as A Controlled Study of Olanzapine in Children with Autism. A Controlled Study of Olanzapine in Children with Autism Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A Controlled Study of Olanzapine in Children with Autism clinical trial. Subjects frequently obtain the most expert healthcare possible for their A Controlled Study of Olanzapine in Children with Autism condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Controlled Study of Olanzapine in Children with Autism  A Controlled Study of Olanzapine in Children with Autism
A Controlled Study of Olanzapine in Children with Autism
For Condition: Autistic Disorder
Status: Recruiting
Sponsor(s): FDA Office of Orphan Products Development ,
Synopsis: This is a 6-week study which investigates the use of olanzapine to decrease symptoms in children, aged 4 to 12 years old, with autism. The study is double-blind and placebo controlled, meaning that patients receive either placebo or olanzapine, and that neither the researchers or the patients know whether or not they are receiving placebo or olanzapine. The purpose in using placebo is that it is otherwise impossible to know how effective the drug is or whether or not the drug causes side effects. Patients treated with placebo can have improvement and can have side effects. In the study patients receive a psychiatric evaluation, physical examination, laboratory tests and study medication (olanzapine or placebo), free of charge. At the end of the 6-week double-blind period, patients can receive 6 weeks of olanzapine as part of the study.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 4 Years/12 Years
Genders: Both
Protocol Entry Criteria: 1. Diagnosis of Autistic Disorder (DSM-IV Criteria). 2. Includes both males and females. 3. Aged 4 to 12 years inclusive. 4. Physically Healthy.
Total Enrollment: 40
Location and Contact Information:
Overall Study Official:
RichardMalone, Principal Investigator, Drexel University College of Medicine
Eastern Pennsylvania Psychiatric Institute *Recruiting*
Philadelphia, Pennsylvania, 19129
United States
Recruiting Richard Malone 215-842-4085
Additional Information:
Study ID Numbers: 2190;
Study Start Date: May 2003
Record last reviewed: March 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00057408
Other Autistic Disorder Studies:
1. Study of Fluoxetine in Adults With Autistic Disorder
2. Treatment of Autism in Children and Adolescents
3. Drug Treatment for Autism
4. A Controlled Study of Olanzapine in Children with Autism
5. Methylphenidate in Children and Adolescents with Pervasive Developmental Disorders
Related Studies:
Other Autistic Disorder Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
A Controlled Study of Olanzapine in Children with Autism
|
|
|
|
|
|
|
|
